Abbott (NYSE:ABT) today edged past Wall Street’s forecast with its 2nd-quarter results, despite a -6% slump for its medical device business, buoyed by a more than 31% boost from its established pharmaceuticals division. The Abbott Park, Ill.-based healthcare giant posted profits of $784 million, or 52¢ per share, on sales of $5.17 billion for the […]
Abbott
Abbott wins FDA nod for Lasik device
Abbott (NYSE:ABT) said today it won FDA premarket approval for its iDesign Advanced WaveScan studio system designed to generate high-definition eye scans used for Lasik surgery. The system’s sensor technology, developed by Abbott, is also being used by NASA in the James Webb Space Telescope, slated to launch in 2018, Chicago-based Abbott said. “The iDesign […]
OrbusNeich launches Chinese Combo stent trial
OrbusNeich said today it launched a Chinese trial of its Combo dual-therapy coronary stent designed to repair vessel injury and regenerate endothelium. The 436-patient randomized, non-inferiority trial has enrolled its 1st patient, the Hong Kong-based company said, and will compare the Combo stent’s effectiveness against Lepu Medical‘s Nano stent for up to 5 years. “We […]
Bayer sells Diabetes Care business to Panasonic Healthcare
(Reuters) — Bayer‘s (ETR:BAYN) has agreed to sell its Diabetes Care business to Panasonic Healthcare Holdings, backed by KKR (NYSE:KKR) and Panasonic (NYSE:PC), for 1.02 billion euros ($1.15 billion), the company said on Wednesday. The deal, expected to be completed in the first quarter of 2016, marks Bayer’s second attempt to divest the blood glucose monitoring […]